Compare SERV & BVS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | SERV | BVS |
|---|---|---|
| Founded | 2017 | 2011 |
| Country | United States | United States |
| Employees | 380 | N/A |
| Industry | Industrial Specialties | Biotechnology: Electromedical & Electrotherapeutic Apparatus |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 705.4M | 617.1M |
| IPO Year | N/A | 2016 |
| Metric | SERV | BVS |
|---|---|---|
| Price | $9.39 | $9.92 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 7 | 3 |
| Target Price | ★ $17.67 | $14.00 |
| AVG Volume (30 Days) | ★ 3.1M | 423.5K |
| Earning Date | 05-07-2026 | 05-05-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 163.46 |
| EPS | N/A | ★ 0.33 |
| Revenue | N/A | ★ $568,087,000.00 |
| Revenue This Year | $920.26 | $7.52 |
| Revenue Next Year | $184.90 | $7.06 |
| P/E Ratio | ★ N/A | $30.36 |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $5.87 | $5.81 |
| 52 Week High | $18.64 | $10.76 |
| Indicator | SERV | BVS |
|---|---|---|
| Relative Strength Index (RSI) | 51.46 | 56.39 |
| Support Level | $9.28 | $8.43 |
| Resistance Level | $10.70 | $10.76 |
| Average True Range (ATR) | 0.53 | 0.43 |
| MACD | 0.10 | -0.02 |
| Stochastic Oscillator | 58.02 | 52.85 |
Serve Robotics Inc is developing next-generation robots for last-mile delivery services. It design, develop and operate low-emissions robots on AI-powered robotics mobility platform, that serve people in public spaces, starting with food delivery. Its first product is a zero-emission robot that serves people in public areas, Starting with food delivery. The Segment derives revenue from (i) services via the Companies robot fleet, including delivery, branding and experiential services, (ii) access to software developed for the robot fleet, including certain autonomous capabilities, and (iii) access to data collected by the robot fleet, including navigation-related data. The majority of the revenue is derived from robot delivery services and food delivery platforms.
Bioventus Inc is a medical device company focused on developing and commercializing products to relieve pain and address musculoskeletal conditions. The company operates through two reporting segments, U.S. and International, and its product portfolio is organized into three main business areas: Pain Treatments, Surgical Solutions, and Restorative Therapies, offering products such as hyaluronic acid injections for osteoarthritis, peripheral nerve stimulation devices, bone graft substitutes, and ultrasound-based fracture healing therapies.